Stimcell Energetics (STME) Return on Capital Employed (2017 - 2019)
Stimcell Energetics (STME) posted quarterly Return on Capital Employed of 6.18% for Q1 2019, down 125.35% quarter-over-quarter from 24.39% in Q4 2018.
Stimcell Energetics (STME) Return on Capital Employed (2017 - 2019) Analysis & Trends
Stimcell Energetics' Return on Capital Employed history runs 3 years deep, the most recent figure standing at 6.18% for Q1 2019.
- In Q1 2019, Return on Capital Employed changed N/A year-over-year to 6.18%; the TTM figure through Feb 2019 stood at 6.18% (changed N/A YoY), while the FY2017 annual figure was 103.27%, changed N/A from the prior year.
- Return on Capital Employed for Q1 2019 stood at 6.18%, down from 24.39% in the prior quarter.
- The five-year high for Return on Capital Employed was 106.24% in Q2 2017, with the low at 6.18% in Q1 2019.
- The 3-year median for Return on Capital Employed is 39.56% (2018), against an average of 44.8%.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 7.98% |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 13.69% |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 8.02% |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 10.83% |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 11.99% |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 27.21% |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 9.47% |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 12.84% |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 12.08% |
| 10 | Stimcell Energetics | 4.65 Mn | 4.64 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2019 | -6.18% |
| Nov 30, 2018 | 24.39% |
| Aug 31, 2018 | 54.74% |
| May 31, 2017 | 106.24% |